Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors: Agonist-Mediated [35s]gtpγs Binding
- 1 April 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (7) , 1035-1043
- https://doi.org/10.1016/s0006-2952(97)00631-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Factors Determining Specificity of Signal Transduction by G-protein-coupled ReceptorsJournal of Biological Chemistry, 1995
- The Cheng-Prusoff relationship: something lost in the translationTrends in Pharmacological Sciences, 1993
- G z -Mediated Hormonal Inhibition of Cyclic AMP accumulationScience, 1992
- Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2.Proceedings of the National Academy of Sciences, 1990
- Cloning, sequence analysis, and permanent expression of a human α2-adrenergic receptor in Chinese hamster ovary cellsJournal of Biological Chemistry, 1989
- Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.Proceedings of the National Academy of Sciences, 1988
- An Examination of the Involvement of Phospholipases A2 and C in the α‐Adrenergic and γ‐Aminobutyric Acid Receptor Modulation of Cyclic AMP Accumulation in Rat Brain SlicesJournal of Neurochemistry, 1986
- α2-Adrenergic Receptors: Apparent Interaction with Multiple Effector SystemsPublished by Elsevier ,1985
- Inhibition of adenylate cyclase by hormones and neurotransmittersMolecular and Cellular Endocrinology, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973